BRPI1008764A2 - microcápsula para liberação controlada para ação osteogênica - Google Patents

microcápsula para liberação controlada para ação osteogênica

Info

Publication number: BRPI1008764A2
Authority: BR; Brazil
Prior art keywords: controlled release; release microcapsule; osteogenic action; osteogenic; action
Prior art date: 2009-02-27

Application number

BRPI1008764A

Other languages

English (en)

Inventor

Kumar Dwivedi Anil

Kumar Avinash

Kumar Gupta Girish

Srivastava Kamini

Chattopadhyay Naibedya

Ranjan Mishra Prabhat

Trivedi Ritu

Kumar Rath Srikanta

Gupta Varsha

Original Assignee

Council Scient Ind Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-27

Filing date

2010-02-26

Publication date

2018-07-24

2010-02-26 Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res

2018-07-24 Publication of BRPI1008764A2 publication Critical patent/BRPI1008764A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI1008764A 2009-02-27 2010-02-26 microcápsula para liberação controlada para ação osteogênica BRPI1008764A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN384DE2009		2009-02-27
PCT/IN2010/000115 WO2010097814A2 (en)	2009-02-27	2010-02-26	A controlled release micro-capsule for osteogenic action

Publications (1)

Publication Number	Publication Date
BRPI1008764A2 true BRPI1008764A2 (pt)	2018-07-24

Family

ID=42543202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008764A BRPI1008764A2 (pt)	2009-02-27	2010-02-26	microcápsula para liberação controlada para ação osteogênica

Country Status (6)

Country	Link
US (1)	US8496964B2 (pt)
EP (1)	EP2400957B1 (pt)
AU (1)	AU2010217238B2 (pt)
BR (1)	BRPI1008764A2 (pt)
CA (1)	CA2753993C (pt)
WO (1)	WO2010097814A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103249405A (zh) *	2010-08-23	2013-08-14	哈佛学院院长等	用于药物递送和其他应用的颗粒
WO2013043812A1 (en) *	2011-09-22	2013-03-28	Board Of Regents Of The University Of Texas System	Logical enzyme triggered (let) layer-by-layer nanocapsules for drug delivery system
EP2841056A4 (en) *	2012-04-23	2015-09-16	Massachusetts Inst Technology	STABLE LAYER COATED PARTICLES
RU2560664C2 (ru) *	2013-07-09	2015-08-20	Александр Александрович Кролевец	Способ получения микрокапсул антиоксиданта с оболочкой из альгината натрия
CN103980888B (zh) *	2014-05-27	2015-06-17	东南大学	一种基于层层组装技术的氧化锌荧光增强的方法
WO2017074262A1 (en) *	2015-10-26	2017-05-04	Agency For Science, Technology And Research	Core-shell composite material
CN105326809B (zh) *	2015-10-27	2018-08-07	武汉理工大学	一种含有CaCO3微粒的复合天然高分子微胶囊的制备方法
CN105497980A (zh) *	2016-01-21	2016-04-20	湖北大学	一种聚多肽生物活性涂层和一种生物材料及其制备方法和应用
WO2019089567A1 (en)	2017-10-30	2019-05-09	Massachusetts Institute Of Technology	Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
CN110123674A (zh) *	2019-05-21	2019-08-16	上海应用技术大学	一种含有美藤果油微胶囊的柔肤水及其制备方法
WO2021002984A1 (en)	2019-05-30	2021-01-07	Massachusetts Institute Of Technology	Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
EP3928859A1 (en) *	2020-06-23	2021-12-29	Omya International AG	Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
CN111991368B (zh) *	2020-09-11	2021-11-12	中国药科大学	一种茶多酚涂层的大豆分离蛋白-季铵盐壳聚糖微胶囊的制备方法
CN114432503A (zh) *	2022-04-12	2022-05-06	北京大学口腔医学院	一种载药骨修复材料及其制备方法和应用
CN115041108B (zh) *	2022-06-27	2023-09-12	江南大学	聚电解质层层组装多酶及其制备方法
CN119857083A (zh) *	2024-12-30	2025-04-22	华西精准医学产业创新中心有限公司	疏水性黄酮类活性分子的载药微球及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6812215B2 (en) *	2000-06-02	2004-11-02	MERCK Patent Gesellschaft mit beschränkter Haftung	Compositions for the treatment of inflammatory joint diseases and osteoporosis
WO2005000831A1 (en) *	2003-06-20	2005-01-06	Cognis France, S.A.S.	ESTERS OF FLAVONOIDS WITH ω-SUBSTITUTED C6-C22 FATTY ACIDS
KR20050081595A (ko) *	2004-02-16	2005-08-19	한국 메디텍 제약 주식회사	캄페롤을 유효성분으로 함유하는 골다공증치료제
MX2008006180A (es) *	2005-11-14	2008-09-22	Louisiana Tech University Res	Peliculas de polipeptido y metodos.
US20070116836A1 (en) *	2005-11-23	2007-05-24	The Coca-Cola Company	High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
ES2345452T3 (es) *	2006-03-15	2010-09-23	Clariant Finance (Bvi) Limited	Pigmentos encapsulados con polielectrolitos.
US20080153831A1 (en) *	2006-10-27	2008-06-26	Sciele Pharma, Inc.	Isoflavone-containing compositions for the treatment of osteoporosis and inflammatory joint disease
CN101557720B (zh) *	2006-12-12	2013-05-29	弗门尼舍有限公司	具有无定形金属盐作为载体的活性成分递送系统
US20110082071A1 (en) *	2008-05-15	2011-04-07	Amal Elabbadi	Delivery system for an active ingredient

2010
- 2010-02-26 AU AU2010217238A patent/AU2010217238B2/en not_active Ceased
- 2010-02-26 US US13/203,603 patent/US8496964B2/en not_active Expired - Fee Related
- 2010-02-26 EP EP10717286.8A patent/EP2400957B1/en not_active Not-in-force
- 2010-02-26 BR BRPI1008764A patent/BRPI1008764A2/pt not_active IP Right Cessation
- 2010-02-26 CA CA2753993A patent/CA2753993C/en not_active Expired - Fee Related
- 2010-02-26 WO PCT/IN2010/000115 patent/WO2010097814A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2010097814A3 (en)	2010-10-28
US8496964B2 (en)	2013-07-30
WO2010097814A2 (en)	2010-09-02
CA2753993C (en)	2017-04-25
US20110305754A1 (en)	2011-12-15
EP2400957A2 (en)	2012-01-04
EP2400957B1 (en)	2013-10-30
AU2010217238B2 (en)	2014-03-06
AU2010217238A1 (en)	2011-09-15
CA2753993A1 (en)	2010-09-02

Publication	Publication Date	Title
BRPI1008764A2 (pt)	2018-07-24	microcápsula para liberação controlada para ação osteogênica
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
BR112013016352A2 (pt)	2018-06-26	reagente de liberação para vitamina d
DK2246321T3 (da)	2011-11-21	Rasagilinformulering med forsinket frisætning
BR112012004807A2 (pt)	2017-04-11	vacina para pcsk9
BRPI1014262A2 (pt)	2017-05-23	anticorpos específicos para caderina-17
PT2435030E (pt)	2015-02-27	Composições farmacêuticas flutuantes de libertação controlada
BRPI1014035A2 (pt)	2016-04-12	método para contracepção.
BR112012004233A2 (pt)	2019-09-24	aparelho para transferência de carga
BR112012010444A2 (pt)	2016-03-08	dispositivo para movimento lateral
BRPI1011337A2 (pt)	2016-03-08	dispositivo de segurança para fixador rápido
BRPI1006122A2 (pt)	2018-02-14	dispositivo para proporcionar uma redução de pressão controlada
ES1071355Y (es)	2010-05-13	Dispositivo antisismico para edificios
HUE053202T2 (hu)	2021-06-28	Gyors hatóanyag-leadású készítmények
ES1065786Y (es)	2008-02-01	Dispositivo de elevacion para canapes
ES1071288Y (es)	2010-05-06	Dispositivo de anclaje para vagones de carga
ES1070148Y (es)	2009-10-16	Macolla para barrotes mejorada
ES1071124Y (es)	2010-04-15	Parapente para aeromodelismo
ES1070340Y (es)	2009-11-02	Dispositivo de ayuda para la incorporacion
ES1070740Y (es)	2010-06-25	Dispositivo de auto-riego para macetas
ES1070688Y (es)	2010-01-14	Dispositivo de soporte para halterofilia
ES1071579Y (es)	2010-06-09	Soporte de sujecion para postes de seguridad
BRPI1013894A2 (pt)	2015-08-25	Método para a liberação de um material volátil.
ES1067760Y (es)	2008-09-16	Dispositivo para descolmataje de mallas para cribado de aridos.
ES1070663Y (es)	2010-01-14	Cenicero exclusivo para c0lillas

Legal Events

Date	Code	Title	Description
2018-08-07	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-08-14	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-12-03	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-12-17	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2019-12-24	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2020-06-23	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2555 DE 24/12/2019.